A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia

Molecular Psychiatry

Volumn 11, Issue 5, 2006, Pages 459-470

  Clark, D ^a,b   Dedova, I ^a,b   Cordwell, S ^a   Matsumoto, I ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Neuroscience Institute of Schizophrenia and Allied Disorders   (Australia)

Author keywords

2D gel electrophoresis; Cingulate cortex; Cytoskeleton; Metabolism; Proteomics; Schizophrenia

Indexed keywords

BRAIN PROTEIN; CYTOSKELETON PROTEIN;

ADULT; ARTICLE; BRAIN FUNCTION; BRAIN METABOLISM; CELL TRANSPORT; CINGULATE GYRUS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOSKELETON; FEMALE; GLIA; GRAY MATTER; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; MORPHOLOGY; NEUROTRANSMISSION; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEOMICS; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYMPTOMATOLOGY; SYNAPSE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; ANALYSIS OF VARIANCE; CYTOSKELETON; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GYRUS CINGULI; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; POSTMORTEM CHANGES; PROTEIN TRANSPORT; PROTEOME; REFERENCE VALUES; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPSES;

EID: 33646355451     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/sj.mp.4001806     Document Type: Article

References (69)

1. Hempel A, Hempel E, Schonknecht P, Stippich C, Schroder J. Impairment in basal limbic function in schizophrenia during affect recognition. Psychiatry Res 2003; 122: 115-124.
2. Carter CS, MacDonald III AW, Ross LL, Stenger VA. Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study. Am J Psychiatry 2001; 158: 1423-1428.
3. Salgado-Pineda P, Baeza I, Perez-Gomez M, Vendrell P, Junque C, Bargallo N et al. Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. Neuroimage 2003; 19(2 Part 1): 365-375.
4. Cleghorn JM, Garnett ES, Nahmias C, Brown GM, Kaplan RD, Szechtman H et al. Regional brain metabolism during auditory hallucinations in chronic schizophrenia. Br J Psychiatry 1990; 157: 562-570.
5. Quintana J, Wong T, Ortiz-Portillo E, Marder SR, Mazziotta JC. Anterior cingulate dysfunction during choice anticipation in schizophrenia. Psychiatry Res 2004; 132: 117-130.
6. Carter CS, Mintun M, Nichols T, Cohen JD. Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance. Am J Psychiatry 1997; 154: 1670-1675.
7. Bouras C, Kovari E, Hof PR, Riederer BM, Giannakopoulos P. Anterior cingulate cortex pathology in schizophrenia and bipolar disorder. Acta Neuropathol (Berlin) 2001; 102: 373-379.
8. Chana G, Landau S, Beasley C, Everall IP, Cotter D. Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biol Psychiatry 2003; 53: 1086-1098.
9. Benes FM, Vincent SL, Todtenkopf M. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry 2001; 50: 395-406.
10. Benes FM, Sorensen I, Vincent SL, Bird ED, Sathi M. Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. Cereb Cortex 1992; 2: 503-512.
11. Benes FM. Emerging principles of altered neural circuitry in schizophrenia. Brain Res Brain Res Rev 2000; 31: 251-269.
12. Benes FM, Todtenkopf MS, Taylor JB. Differential distribution of tyrosine hydroxylase fibers on small and large neurons in layer II of anterior cingulate cortex of schizophrenic brain. Synapse 1997; 25: 80-92.
13. Woo TU, Walsh JP, Benes FM. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 2004; 61: 649-657.
14. Kalus P, Senitz D, Lauer M, Beckmann H. Inhibitory cartridge synapses in the anterior cingulate cortex of schizophrenics. J Neural Transm 1999; 106: 763-771.
15. Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP. Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 1992; 12: 924-929.
16. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993; 262: 689-695.
17. Jiang L, Lindpaintaer K, Li HF, Gu NF, Langen H, He L et al. Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia. Amino Acids 2003; 25: 49-57.
18. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 2004; 9: 684-697, 643.
19. Johnston-Wilson NL, Sims CD, Hofmann JP, Anderson L, Shore AD, Torrey EF et al. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol Psychiatry 2000; 5: 142-149.
20. Edgar PF, Douglas JE, Cooper GJ, Dean B, Kydd R, Faull RL. Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia. Mol. Psychiatry 2000; 5: 85-90.
21. Vogt BA, Nimchinsky EA, Vogt LJ, Hof PR. Human cingulate cortex: surface features, flat maps, and cytoarchitecture. J Comp Neurol 1995; 359: 490-506.
22. American PA. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington DC, 1994.
23. Alexander-Kaufman A, James G, Sheedy D, Harper C, Matsumoto I. Differential protein expression in the prefrontaol white matter of human alcoholics: a proteomics study. Mol Psychiatry 2006; 11: 56-65.
24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
25. Harrison PJ, Heath PR, Eastwood SL, Burnet PW, McDonald B, Pearson RC. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 1995; 200: 151-154.
26. Kingsbury AE, Foster OJ, Nisbet AP, Cairns N, Bray L, Eve DJ et al. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res 1995; 28: 311-318.
27. Fountoulakis M, Hardmeier R, Hoger H, Lubec G. Postmortem changes in the level of brain proteins. Exp Neurol 2001; 167: 86-94.
28. Thompson PM, Sower AC, Perrone-Bizzozero NI. Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia. Biol Psychiatry 1998; 43: 239-243.
29. Maurer I, Zierz S, Moller H. Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr Res 2001; 48: 125-136.
30. Klushnik TP, Spunde A, Yakovlev AG, Khuchua ZA, Saks VA, Vartanyan ME. Intracellular alterations of the creatine kinase isoforms in brains of schizophrenic patients. Mol Chem Neuropathol 1991; 15: 271-280.
31. Mukerjee S, Mahadik SP, Scheffer R, Correnti EE, Kelkar H. Impaired antioxidant defense at the onset of psychosis. Schizophr Res 1996; 19: 19-26.
32. Kim JJ, Lee SJ, Toh KY, Lee CU, Lee C, Paik IH. Identification of antibodies to heat shock proteins 90 and 70 kDa in patients with schizophrenia. Schizophr Res 2001; 52: 127-135.
33. Willson VJ, Graham JG, McQueen IN, Thompson RJ. Immunoreactive aldolase C in cerebrospinal fluid of patients with neurological disorders. Ann Clin Biochem 1980; 17: 110-113.
34. Altar CA, Jurata LW, Charles V, Lemire A, Liu P, Bukhman Y et al. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 2005; 58: 85-96.
35. Dror N, Klein E, Karry R, Sheinkman A, Kirsh Z, Mazor M et al. State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia. Mol Psychiatry 2002; 7: 995-1001.
36. Hallmayer J. Chromosomes 1, 2, and 7 workshop. Am J Med Genet 1999; 88: 219-223.
37. Ekelund J, Lichtermann D, Hovatta I, Ellonen P, Suvisaari J, Terwilliger JD et al. Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22. Hum Mol Genet 2000; 9: 1049-1057.
38. Molloy GR, Wilson CD, Benfield P, de Vellis J, Kumar S. Rat brain creatine kinase messenger RNA levels are high in primary cultures of brain astrocytes and oligodendrocytes and low in neurons. J Neurochem 1992; 59: 1925-1932.
39. Tachikawa M, Fukaya M, Terasaki T, Ohtsuki S, Watanabe M. Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuronglial relationship for brain energy homeostasis. Eur J Neurosci 2004; 20: 144-160.
40. Hemmer W, Wallimann T. Functional aspects of creatine kinase in brain. Dev Neurosci 1993; 15: 249-260.
41. Jost CR, Van Der Zee CE, In 't Zandt HJ, Oerlemans F, Verheij M, Streijger F et al. Creatine kinase B-driven energy transfer in the brain is important for habituation and spatial learning behaviour, mossy fibre field size and determination of seizure susceptibility. Eur J Neurosci 2002; 15: 1692-1706.
42. Burbaeva G, Savushkina OK, Boksha IS. Creatine kinase BB in brain in schizophrenia. World J Biol Psychiatry 2003; 4: 177-183.
43. Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J 1992; 281(Part 1): 21-40.
44. Schwartz PJ, Reaume A, Scott R, Coyle JT. Effects of over- and under-expression of Cu, Zn-superoxide dismutase on the toxicity of glutamate analogs in transgenic mouse striatum. Brain Res 1998; 789: 32-39.
45. Tsai G, Goff DC, Chang RW, Flood J, Baer L, Coyle JT. Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia. Am J Psychiatry 1998; 155: 1207-1213.
46. Zhang XY, Zhou DF, Cao LY, Chen da C, Zhu FY, Wu GY. Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements. Schizophr Res 2003; 62: 245-250.
47. Dakhale G, Khanzode S, Saoji A, Khobragade L, Turankar A. Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics. Neuropsychobiology 2004; 49: 205-209.
48. Thornalley PJ. The glyoxalase system in health and disease. Mol Aspects Med 1993; 14: 287-371.
49. Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN et al. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 1992; 49: 522-530.
50. Haznedar MM, Buchsbaum MS, Luu C, Hazlett EA, Siegel Jr BV, Lohr J et al. Decreased anterior cingulate gyrus metabolic rate in schizophrenia. Am J Psychiatry 1997; 154: 682-684.
51. Di Paolo G, Antonsson B, Kassel D, Riederer BM, Grenningloh G. Phosphorylation regulates the microtubule-destabilizing activity of stathmin and its interaction with tubulin. FEBS Lett 1997; 416: 149-152.
52. Zhu J, Zhou K, Hao JJ, Liu J, Smith N, Zhan X. Regulation of cortactin/dynamin interaction by actin polymerization during the fission of clathrin-coated pits. J Cell Sci 2005; 118(Part 4): 807-817.
53. Paulson L, Martin P, Nilsson CL, Ljung E, Westman-Brinkmalm A, Blennow K et al. Comparative proteome analysis of thalamus in MK-801-treated rats. Proteomics 2004; 4: 819-825.
54. Mori N, Morii H. SCG10-related neuronal growth-associated proteins in neural development, plasticity, degeneration, and aging. J Neurosci Res 2002; 70: 264-273.
55. Nishiki T, Nihonmatsu I, Tsuhara Y, Kawasaki M, Sekiguchi M, Sato K et al. Distribution of soluble N-ethylmaleimide fusion protein attachment proteins (SNAPs) in the rat nervous system. Neuroscience 2001; 107: 363-371.
56. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000; 28: 53-67.
57. Imai C, Sugai T, Iritani S, Niizato K, Nakamura R, Makifuchi T et al. A quantitative study on the expression of synapsin II and N-ethylmaleimide-sensitive fusion protein in schizophrenic patients. Neurosci Lett 2001; 305: 185-188.
58. Gray L, Scarr E, Dean B. N-Ethylmaleimide sensitive factor in the cortex of subjects with schizophrenia and bipolar I disorder. Neurosci Lett 2006; 391: 112-115.
59. Bordelon JR, Smith Y, Nairn AC, Colbran RJ, Greengard P, Muly EC. Differential localization of protein phosphatase-1{alpha}, {beta} and {gamma}1 isoforms in primate prefrontal cortex. Cereb Cortex 2005; 15: 1928-1937.
60. Cohen PT. Protein phosphatase 1 - targeted in many directions. J Cell Sci 2002; 115(Part 2): 241-256.
61. Svenningsson P, Tzavara ET, Carruthers R, Rachleff I, Wattler S, Nehls M et al. Diverse psychotomimetics act through a common signaling pathway. Science 2003; 302: 1412-1415.
62. Yang CQ, Kitamura N, Nishino N, Shirakawa O, Nakai H. Isotype-specific G protein abnormalities in the left superior temporal cortex and limbic structures of patients with chronic schizophrenia. Biol Psychiatry 1998; 43: 12-19.
63. Moore C, Perry AC, Love S, Hall L. Sequence analysis and immunolocalisation of phosphatidylethanolamine binding protein (PBP) in human brain tissue. Brain Res Mol Brain Res 1996; 37: 74-78.
64. Seddiqi N, Bollengier F, Alliel PM, Perin JP, Bonnet F, Bucquoy S et al. Amino acid sequence of the Homo sapiens brain 21-23-kDa protein (neuropolypeptide h3), comparison with its counterparts from Rattus norvegicus and Bos taurus species, and expression of its mRNA in different tissues. J Mol Evol 1994; 39: 655-660.
65. Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem 2002; 82: 1524-1532.
66. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998; 95: 13290-13295.
67. Cotter D, Mackay D, Landau S, Kerwin R, Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 2001; 58: 545-553.
68. Meyer-Franke A, Shen S, Barres BA. Astrocytes induce oligodendrocyte processes to align with and adhere to axons. Mol Cell Neurosci 1999; 14: 385-397.
69. Webster MJ, O'Grady J, Kleinman JE, Weickert CS. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia. Neuroscience 2005; 133: 453-461.